These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38466015)

  • 1. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles.
    Mangioris G; Halfdanarson TR; Lennon VA; Chang BK; Dubey D; Dyck PJB; Flanagan EP; McKeon A; Mills JR; Pittock SJ; Zekeridou A
    Eur J Neurol; 2024 Jun; 31(6):e16273. PubMed ID: 38466015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
    Zekeridou A; Majed M; Heliopoulos I; Lennon VA
    Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
    Sechi E; Markovic SN; McKeon A; Dubey D; Liewluck T; Lennon VA; Lopez-Chiriboga AS; Klein CJ; Mauermann M; Pittock SJ; Flanagan EP; Zekeridou A
    Neurology; 2020 Oct; 95(17):e2442-e2452. PubMed ID: 32796130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor-associated central nervous system autoimmunity.
    Valencia-Sanchez C; Sechi E; Dubey D; Flanagan EP; McKeon A; Pittock SJ; Zekeridou A
    Eur J Neurol; 2023 Aug; 30(8):2418-2429. PubMed ID: 37151179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
    Zekeridou A; McKeon A; Lennon VA
    JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.
    Fang B; McKeon A; Hinson SR; Kryzer TJ; Pittock SJ; Aksamit AJ; Lennon VA
    JAMA Neurol; 2016 Nov; 73(11):1297-1307. PubMed ID: 27618707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments.
    McKeon A; Lennon VA; Lachance DH; Fealey RD; Pittock SJ
    Arch Neurol; 2009 Jun; 66(6):735-41. PubMed ID: 19506133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic neuronal intermediate filament autoimmunity.
    Basal E; Zalewski N; Kryzer TJ; Hinson SR; Guo Y; Dubey D; Benarroch EE; Lucchinetti CF; Pittock SJ; Lennon VA; McKeon A
    Neurology; 2018 Oct; 91(18):e1677-e1689. PubMed ID: 30282771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Immune-Mediated Paraneoplastic Syndromes to Neurological Manifestations of Neuroendocrine Tumours: A Retrospective Study.
    Tannoury J; de Mestier L; Hentic O; Ruszniewski P; Créange A; Sobhani I
    Neuroendocrinology; 2021; 111(1-2):123-128. PubMed ID: 32040952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.
    Popkirov S; Ayzenberg I; Hahn S; Bauer J; Denno Y; Rieckhoff N; Radzimski C; Hans VH; Berg S; Roghmann F; Noldus J; Bien CG; Skodda S; Wellmer J; Stöcker W; Krogias C; Gold R; Schlegel U; Probst C; Komorowski L; Miske R; Kleiter I
    Acta Neuropathol Commun; 2017 May; 5(1):40. PubMed ID: 28554330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause.
    Yanagihashi M; Kawabe K; Ikeda K
    J Neurol Sci; 2013 Dec; 335(1-2):197-200. PubMed ID: 24094858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery.
    Segal Y; Zekeridou A
    Curr Opin Neurol; 2024 Jun; 37(3):295-304. PubMed ID: 38533672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors.
    Vilaseca A; Farina A; Villagrán-García M; Pegat A; Benaiteau M; Ciano-Petersen NL; Do LD; Rogemond V; Gonçalves D; Psimaras D; Birzu C; Honnorat J; Joubert B
    J Neurol; 2024 Jun; 271(6):3279-3290. PubMed ID: 38467790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin-4 autoantibodies in a paraneoplastic context.
    Pittock SJ; Lennon VA
    Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.
    Zalewski NL; Lennon VA; Lachance DH; Klein CJ; Pittock SJ; Mckeon A
    Muscle Nerve; 2016 Aug; 54(2):220-7. PubMed ID: 26789908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.
    Thieben MJ; Lennon VA; Boeve BF; Aksamit AJ; Keegan M; Vernino S
    Neurology; 2004 Apr; 62(7):1177-82. PubMed ID: 15079019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
    Müller-Jensen L; Knauss S; Ginesta Roque L; Schinke C; Maierhof SK; Bartels F; Finke C; Rentzsch K; Ulrich C; Mohr R; Stenzel W; Endres M; Boehmerle W; Huehnchen P
    Front Immunol; 2023; 14():1108116. PubMed ID: 36845122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.